Exact Mass: 759.5566

Exact Mass Matches: 759.5566

Found 500 metabolites which its exact mass value is equals to given mass value 759.5566, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(16:0/18:1(9Z))

(2-{[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(16:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine is a phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively. It has a role as a mouse metabolite. It is a phosphatidylcholine 34:1 and a 1-acyl-2-oleoyl-sn-glycero-3-phosphocholine betaine. It is functionally related to a hexadecanoic acid and an oleic acid. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine is a natural product found in Streptomyces roseicoloratus, Vitis vinifera, and other organisms with data available. PC(16:0/18:1(9Z)) is a metabolite found in or produced by Saccharomyces cerevisiae. PC(16:0/18:1(9z)) is a phosphatidylchloline (PC). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylcholines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PC(16:0/18:1(9z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. In E. coli, PCs can be found in the integral component of the cell outer membrane. They are hydrolyzed by Phospholipases to a 2-acylglycerophosphocholine and a carboxylate. A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively.

   

PC(14:0/20:1(11Z))

(2-{[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(14:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(14:1(9Z)/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(14:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/20:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/20:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(16:0/18:1(11Z))

(2-{[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(16:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:1(9Z)/18:0)

(2-{[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(16:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/18:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:0/16:1(9Z))

(2-{[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(18:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(11Z)/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/16:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/16:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(9Z)/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(18:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/16:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(20:0/14:1(9Z))

(2-{[(2R)-3-(icosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(20:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/14:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(20:1(11Z)/14:0)

(2-{[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


PC(20:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/14:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/14:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(15:0/22:1(13Z))

(2-aminoethoxy)[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphinic acid

C42H82NO8P (759.5778)


PE(15:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of erucic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(22:1(13Z)/15:0)

(2-aminoethoxy)[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(pentadecanoyloxy)propoxy]phosphinic acid

C42H82NO8P (759.5778)


PE(22:1(13Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/15:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:1(13Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/15:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(18:0/18:1(9Z))

[2-(methylamino)ethoxy]({2-[(9Z)-octadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(18:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/18:1(9Z)), in particular, consists of one octadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(18:0/18:1(11Z))

[2-(methylamino)ethoxy]({2-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(18:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/18:1(11Z)), in particular, consists of one octadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:1(9Z)/22:0)

[2-(docosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(14:1(9Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/22:0), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one docosanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:0/20:1(11Z))

[3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(16:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/20:1(11Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:1(9Z)/20:0)

{3-[(9Z)-hexadec-9-enoyloxy]-2-(icosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(16:1(9Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/20:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:0/22:1(13Z))

{2-[(13Z)-docos-13-enoyloxy]-3-(tetradecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(14:0/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(11Z)/18:0)

[2-(methylamino)ethoxy]({3-[(11Z)-octadec-11-enoyloxy]-2-(octadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(18:1(11Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/18:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(9Z)/18:0)

[2-(methylamino)ethoxy]({3-[(9Z)-octadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(18:1(9Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:0/16:1(9Z))

{2-[(9Z)-hexadec-9-enoyloxy]-3-(icosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(20:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/16:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:1(11Z)/16:0)

[2-(hexadecanoyloxy)-3-[(11Z)-icos-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(20:1(11Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/16:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:0/14:1(9Z))

[3-(docosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(22:0/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/14:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:1(13Z)/14:0)

{3-[(13Z)-docos-13-enoyloxy]-2-(tetradecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C42H82NO8P (759.5778)


PE-NMe(22:1(13Z)/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/14:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/20:1(11Z))

[2-(dimethylamino)ethoxy]({2-[(11Z)-icos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe2(15:0/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/20:1(11Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(20:1(11Z)/15:0)

[2-(dimethylamino)ethoxy]({3-[(11Z)-icos-11-enoyloxy]-2-(pentadecanoyloxy)propoxy})phosphinic acid

C42H82NO8P (759.5778)


PE-NMe2(20:1(11Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

(2-{[3-(hexadecanoyloxy)-2-(octadec-9-enoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


   

PE(18:0/18:1(12Z)-O(9S,10R))

(2-aminoethoxy)[(2R)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one octadecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(12Z)-O(9S,10R)/18:0)

(2-aminoethoxy)[(2R)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-2-(octadecanoyloxy)propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:1(12Z)-O(9S,10R)/18:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-O(9S,10R)/18:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of octadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:0/18:1(9Z)-O(12,13))

(2-aminoethoxy)[(2R)-3-(octadecanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one octadecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(9Z)-O(12,13)/18:0)

(2-aminoethoxy)[(2R)-2-(octadecanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:1(9Z)-O(12,13)/18:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(9Z)-O(12,13)/18:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of octadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(P-18:1(11Z)/18:1(12Z)-2OH(9,10))

(2-aminoethoxy)[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-[(1E,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(P-18:1(11Z)/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(P-18:1(11Z)/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 1Z,11Z-octadecadienyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(12Z)-2OH(9,10)/P-18:1(11Z))

(2-aminoethoxy)[(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-[(1E,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:1(12Z)-2OH(9,10)/P-18:1(11Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-2OH(9,10)/P-18:1(11Z)), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 1Z,11Z-octadecadienyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(P-18:1(9Z)/18:1(12Z)-2OH(9,10))

(2-aminoethoxy)[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-[(1E,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(P-18:1(9Z)/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(P-18:1(9Z)/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 1Z,9Z-octadecadienyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(12Z)-2OH(9,10)/P-18:1(9Z))

(2-aminoethoxy)[(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-[(1E,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C41H78NO9P (759.5414)


PE(18:1(12Z)-2OH(9,10)/P-18:1(9Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-2OH(9,10)/P-18:1(9Z)), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 1Z,9Z-octadecadienyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PC(15:0/18:1(12Z)-O(9S,10R))

trimethyl(2-{[(2R)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-3-(pentadecanoyloxy)propyl phosphono]oxy}ethyl)azanium

C41H78NO9P (759.5414)


PC(15:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(15:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one pentadecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

PC(18:1(12Z)-O(9S,10R)/15:0)

trimethyl(2-{[(2R)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-2-(pentadecanoyloxy)propyl phosphono]oxy}ethyl)azanium

C41H78NO9P (759.5414)


PC(18:1(12Z)-O(9S,10R)/15:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-O(9S,10R)/15:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of pentadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

PC(15:0/18:1(9Z)-O(12,13))

trimethyl(2-{[(2R)-3-(pentadecanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propyl phosphono]oxy}ethyl)azanium

C41H78NO9P (759.5414)


PC(15:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(15:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one pentadecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

PC(18:1(9Z)-O(12,13)/15:0)

trimethyl(2-{[(2R)-2-(pentadecanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propyl phosphono]oxy}ethyl)azanium

C41H78NO9P (759.5414)


PC(18:1(9Z)-O(12,13)/15:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(9Z)-O(12,13)/15:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of pentadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

   

Phosphatidylcholine 16:0-18:1

Phosphatidylcholine 16:0-18:1

C42H82NO8P (759.5778)


   

Phosphatidylethanolamine 18:1-19:0

Phosphatidylethanolamine 18:1-19:0

C42H82NO8P (759.5778)


   

PC(16:0e/13-HODE)

PC(16:0e/13-HODE)

C42H82NO8P (759.5778)


   

PE(18:0/9-HODE)

PE(18:0/9-HODE)

C41H78NO9P (759.5414)


   

1-O-(beta-D-glucopyranosyloxy)-(2S,3S,4R,6E)-2-[(2R)-2-hydroxyheptadecanoylamino]-8-nonadecene-3,4-diol

1-O-(beta-D-glucopyranosyloxy)-(2S,3S,4R,6E)-2-[(2R)-2-hydroxyheptadecanoylamino]-8-nonadecene-3,4-diol

C42H81NO10 (759.586)


   

PC 34:1

1-(11Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


Found in mouse brain; TwoDicalId=16; MgfFile=160720_brain_AA_19_Neg; MgfId=1172

   

1-Palmitoyl-2-oleoyl-sn-glycero-3-PC

(2-{[3-(hexadecanoyloxy)-2-[octadec-9-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


   

PC(16:0/18:1(9Z))

PC(16:0/18:1(9Z))

C42H82NO8P (759.5778)


   

PC(16:0/18:1)

3,5,8-Trioxa-4-phosphahexacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide, [R-(E)]-

C42H82NO8P (759.5778)


   

PC(16:0/18:1)[U]

3,5,8-Trioxa-4-phosphahexacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide, (E)-

C42H82NO8P (759.5778)


   

PC(16:0/18:1)[S]

Choline, hydroxide, dihydrogen phosphate, inner salt, ester with 1-palmito-2-olein, D-

C42H82NO8P (759.5778)


   

PC(16:1/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxo-9-hexadecenyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C42H82NO8P (759.5778)


   

PC(18:1/16:0)[U]

3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (E)-

C42H82NO8P (759.5778)


   

1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C45H78NO6P (759.5566)


   

Lecithin

1-arachidonyl-2-myristoleoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PE(37:1)

1-Erucoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PC(12:0/22:1(11Z))

1-dodecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(15:0/19:1(9Z))

1-pentadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(15:1(9Z)/19:0)

1-(9Z-pentadecenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(17:0/17:1(9Z))

1-heptadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(17:1(9Z)/17:0)

1-(9Z-heptadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(19:0/15:1(9Z))

1-nonadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(19:1(9Z)/15:0)

1-(9Z-nonadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PC(22:1(11Z)/12:0)

1-(11Z-docosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

PE(15:0/22:1(11Z))

1-pentadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(15:1(9Z)/22:0)

1-(9Z-pentadecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(16:1(9Z)/21:0)

1-(9Z-hexadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(17:0/20:1(11Z))

1-heptadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(17:1(9Z)/20:0)

1-(9Z-heptadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(18:0/19:1(9Z))

1-octadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(18:1(9Z)/19:0)

1-(9Z-octadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(19:0/18:1(9Z))

1-nonadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(19:1(9Z)/18:0)

1-(9Z-nonadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(20:0/17:1(9Z))

1-eicosanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(20:1(11Z)/17:0)

1-(11Z-eicosenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(21:0/16:1(9Z))

1-heneicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(22:0/15:1(9Z))

1-docosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE(22:1(11Z)/15:0)

1-(11Z-docosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PS(O-18:0/17:2(9Z,12Z))

1-octadecyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

PS(P-16:0/19:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

PS(P-18:0/17:1(9Z))

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

PS(P-20:0/15:1(9Z))

1-(1Z-eicosenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

PE 37:1

1-heneicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

PE dO-40:8

1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C45H78NO6P (759.5566)


   

PS O-35:2

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

HexCer 36:1;O4

N-(2R-hydroxyoctadecanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine

C42H81NO10 (759.586)


   

Phosphatidylcholines (PC)

[2-hexadecanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine

C42H82NO8P (759.5778)


   

1-palmitoyl-2-oleoylphosphatidylcholine

1-palmitoyl-2-oleoylphosphatidylcholine

C42H82NO8P (759.5778)


   

2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine

2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

2-azaniumylethyl (2S)-2,3-bis{[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}propyl phosphate

2-azaniumylethyl (2S)-2,3-bis{[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}propyl phosphate

C45H78NO6P (759.5566)


   

2-aminoethyl (2S)-2,3-bis{[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}propyl hydrogen phosphate

2-aminoethyl (2S)-2,3-bis{[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]oxy}propyl hydrogen phosphate

C45H78NO6P (759.5566)


   

PE(18:0/18:1(12Z)-O(9S,10R))

PE(18:0/18:1(12Z)-O(9S,10R))

C41H78NO9P (759.5414)


   

PE(18:1(12Z)-O(9S,10R)/18:0)

PE(18:1(12Z)-O(9S,10R)/18:0)

C41H78NO9P (759.5414)


   

PC(15:0/18:1(12Z)-O(9S,10R))

PC(15:0/18:1(12Z)-O(9S,10R))

C41H78NO9P (759.5414)


   

PC(18:1(12Z)-O(9S,10R)/15:0)

PC(18:1(12Z)-O(9S,10R)/15:0)

C41H78NO9P (759.5414)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] octadecanoate

C41H78NO9P (759.5414)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] octadecanoate

C41H78NO9P (759.5414)


   

[(2R)-3-pentadecanoyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-pentadecanoyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H78NO9P (759.5414)


   

[(2R)-2-pentadecanoyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-pentadecanoyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H78NO9P (759.5414)


   

PE(P-18:1(9Z)/18:1(12Z)-2OH(9,10))

PE(P-18:1(9Z)/18:1(12Z)-2OH(9,10))

C41H78NO9P (759.5414)


   

PE(18:1(12Z)-2OH(9,10)/P-18:1(9Z))

PE(18:1(12Z)-2OH(9,10)/P-18:1(9Z))

C41H78NO9P (759.5414)


   

PE(P-18:1(11Z)/18:1(12Z)-2OH(9,10))

PE(P-18:1(11Z)/18:1(12Z)-2OH(9,10))

C41H78NO9P (759.5414)


   

PE(18:1(12Z)-2OH(9,10)/P-18:1(11Z))

PE(18:1(12Z)-2OH(9,10)/P-18:1(11Z))

C41H78NO9P (759.5414)


   

2-[[(E,2S,3R)-2-[[(Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]pent-3-enoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E,2S,3R)-2-[[(Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]pent-3-enoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H76N2O9P+ (759.5288)


   

2-[[(2S,3R,4E,14Z)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyoctadeca-4,14-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,14Z)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyoctadeca-4,14-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C41H80N2O8P+ (759.5652)


   
   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] nonadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C42H82NO8P (759.5778)


   

HexCer 9:0;2O/30:6

HexCer 9:0;2O/30:6

C45H77NO8 (759.5649)


   

HexCer 9:1;2O/30:5

HexCer 9:1;2O/30:5

C45H77NO8 (759.5649)


   

NAGly 26:7/21:2

NAGly 26:7/21:2

C49H77NO5 (759.5801)


   

HexCer 13:0;2O/26:6

HexCer 13:0;2O/26:6

C45H77NO8 (759.5649)


   

HexCer 21:3;2O/18:3

HexCer 21:3;2O/18:3

C45H77NO8 (759.5649)


   

HexCer 13:2;2O/26:4

HexCer 13:2;2O/26:4

C45H77NO8 (759.5649)


   

HexCer 15:1;2O/24:5

HexCer 15:1;2O/24:5

C45H77NO8 (759.5649)


   

HexCer 23:3;2O/16:3

HexCer 23:3;2O/16:3

C45H77NO8 (759.5649)


   

HexCer 19:1;2O/20:5

HexCer 19:1;2O/20:5

C45H77NO8 (759.5649)


   

HexCer 11:0;2O/28:6

HexCer 11:0;2O/28:6

C45H77NO8 (759.5649)


   

HexCer 21:1;2O/18:5

HexCer 21:1;2O/18:5

C45H77NO8 (759.5649)


   

HexCer 23:2;2O/16:4

HexCer 23:2;2O/16:4

C45H77NO8 (759.5649)


   

HexCer 15:2;2O/24:4

HexCer 15:2;2O/24:4

C45H77NO8 (759.5649)


   

HexCer 13:1;2O/26:5

HexCer 13:1;2O/26:5

C45H77NO8 (759.5649)


   

HexCer 21:2;2O/18:4

HexCer 21:2;2O/18:4

C45H77NO8 (759.5649)


   

HexCer 19:3;2O/20:3

HexCer 19:3;2O/20:3

C45H77NO8 (759.5649)


   

HexCer 17:2;2O/22:4

HexCer 17:2;2O/22:4

C45H77NO8 (759.5649)


   

HexCer 15:0;2O/24:6

HexCer 15:0;2O/24:6

C45H77NO8 (759.5649)


   

HexCer 17:3;2O/22:3

HexCer 17:3;2O/22:3

C45H77NO8 (759.5649)


   

HexCer 17:0;2O/22:6

HexCer 17:0;2O/22:6

C45H77NO8 (759.5649)


   

HexCer 11:1;2O/28:5

HexCer 11:1;2O/28:5

C45H77NO8 (759.5649)


   

HexCer 15:3;2O/24:3

HexCer 15:3;2O/24:3

C45H77NO8 (759.5649)


   

HexCer 17:1;2O/22:5

HexCer 17:1;2O/22:5

C45H77NO8 (759.5649)


   

HexCer 19:2;2O/20:4

HexCer 19:2;2O/20:4

C45H77NO8 (759.5649)


   

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-nonanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-nonanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

Lnape 16:0/N-21:1

Lnape 16:0/N-21:1

C42H82NO8P (759.5778)


   

Lnape 19:1/N-18:0

Lnape 19:1/N-18:0

C42H82NO8P (759.5778)


   

Lnape 19:0/N-18:1

Lnape 19:0/N-18:1

C42H82NO8P (759.5778)


   

Lnape 13:1/N-24:0

Lnape 13:1/N-24:0

C42H82NO8P (759.5778)


   

Lnape 22:1/N-15:0

Lnape 22:1/N-15:0

C42H82NO8P (759.5778)


   

Lnape 13:0/N-24:1

Lnape 13:0/N-24:1

C42H82NO8P (759.5778)


   

Lnape 18:0/N-19:1

Lnape 18:0/N-19:1

C42H82NO8P (759.5778)


   

Lnape 20:1/N-17:0

Lnape 20:1/N-17:0

C42H82NO8P (759.5778)


   

Lnape 26:1/N-11:0

Lnape 26:1/N-11:0

C42H82NO8P (759.5778)


   

Lnape 24:1/N-13:0

Lnape 24:1/N-13:0

C42H82NO8P (759.5778)


   

Lnape 11:0/N-26:1

Lnape 11:0/N-26:1

C42H82NO8P (759.5778)


   

Lnape 21:0/N-16:1

Lnape 21:0/N-16:1

C42H82NO8P (759.5778)


   

Lnape 14:1/N-23:0

Lnape 14:1/N-23:0

C42H82NO8P (759.5778)


   

Lnape 17:1/N-20:0

Lnape 17:1/N-20:0

C42H82NO8P (759.5778)


   

Lnape 22:0/N-15:1

Lnape 22:0/N-15:1

C42H82NO8P (759.5778)


   

Lnape 15:1/N-22:0

Lnape 15:1/N-22:0

C42H82NO8P (759.5778)


   

Lnape 18:1/N-19:0

Lnape 18:1/N-19:0

C42H82NO8P (759.5778)


   

Lnape 15:0/N-22:1

Lnape 15:0/N-22:1

C42H82NO8P (759.5778)


   

Lnape 24:0/N-13:1

Lnape 24:0/N-13:1

C42H82NO8P (759.5778)


   

Lnape 16:1/N-21:0

Lnape 16:1/N-21:0

C42H82NO8P (759.5778)


   

Lnape 17:0/N-20:1

Lnape 17:0/N-20:1

C42H82NO8P (759.5778)


   

Lnape 23:0/N-14:1

Lnape 23:0/N-14:1

C42H82NO8P (759.5778)


   

Lnape 21:1/N-16:0

Lnape 21:1/N-16:0

C42H82NO8P (759.5778)


   

Lnape 20:0/N-17:1

Lnape 20:0/N-17:1

C42H82NO8P (759.5778)


   

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[3-heptadecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-heptadecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

2-[2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C45H77NO8 (759.5649)


   

HexCer 8:0;3O/28:1;(2OH)

HexCer 8:0;3O/28:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 9:0;3O/27:1;(2OH)

HexCer 9:0;3O/27:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 10:0;3O/26:1;(2OH)

HexCer 10:0;3O/26:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 13:1;3O/23:0;(2OH)

HexCer 13:1;3O/23:0;(2OH)

C42H81NO10 (759.586)


   

HexCer 12:1;3O/24:0;(2OH)

HexCer 12:1;3O/24:0;(2OH)

C42H81NO10 (759.586)


   

HexCer 13:0;3O/23:1;(2OH)

HexCer 13:0;3O/23:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 12:0;3O/24:1;(2OH)

HexCer 12:0;3O/24:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 11:0;3O/25:1;(2OH)

HexCer 11:0;3O/25:1;(2OH)

C42H81NO10 (759.586)


   

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]docosane-1-sulfonic acid

C46H81NO5S (759.5835)


   

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

C46H81NO5S (759.5835)


   

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyicosane-1-sulfonic acid

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyicosane-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]docosa-4,8-diene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyicos-4-ene-1-sulfonic acid

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyicos-4-ene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]docos-4-ene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyicosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyicosa-4,8-diene-1-sulfonic acid

C46H81NO5S (759.5835)


   

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

C46H81NO5S (759.5835)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C46H81NO5S (759.5835)


   

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(Z)-docos-13-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-docos-13-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tetradecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tetradecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-hexadecanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-hexadecanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-undecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-undecoxypropoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-heptadecoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-heptadecoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-hexadecoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-hexadecoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[hydroxy-[3-[(13Z,16Z)-tetracosa-13,16-dienoxy]-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(13Z,16Z)-tetracosa-13,16-dienoxy]-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-nonadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-nonadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(Z)-henicos-11-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-henicos-11-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-amino-3-[[2-heptadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-heptadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H78NO9P (759.5414)


   

2-[4-[10,13-dimethyl-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

2-[4-[10,13-dimethyl-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C45H77NO6S (759.5471)


   

2-[4-[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C48H73NO6 (759.5438)


   

Cer 17:0;2O/16:5;(3OH)(FA 16:5)

Cer 17:0;2O/16:5;(3OH)(FA 16:5)

C49H77NO5 (759.5801)


   

Cer 14:0;2O/16:5;(3OH)(FA 19:5)

Cer 14:0;2O/16:5;(3OH)(FA 19:5)

C49H77NO5 (759.5801)


   

Cer 15:0;2O/16:5;(3OH)(FA 18:5)

Cer 15:0;2O/16:5;(3OH)(FA 18:5)

C49H77NO5 (759.5801)


   

Cer 14:0;2O/19:5;(3OH)(FA 16:5)

Cer 14:0;2O/19:5;(3OH)(FA 16:5)

C49H77NO5 (759.5801)


   

Cer 15:0;2O/18:5;(3OH)(FA 16:5)

Cer 15:0;2O/18:5;(3OH)(FA 16:5)

C49H77NO5 (759.5801)


   

OxPC 34:1e+1O(1Cyc)

OxPC 34:1e+1O(1Cyc)

C42H82NO8P (759.5778)


   

HexCer 24:1;3O/12:0;(2OH)

HexCer 24:1;3O/12:0;(2OH)

C42H81NO10 (759.586)


   

HexCer 23:0;3O/13:1;(2OH)

HexCer 23:0;3O/13:1;(2OH)

C42H81NO10 (759.586)


   

HexCer 20:1;3O/16:0;(2OH)

HexCer 20:1;3O/16:0;(2OH)

C42H81NO10 (759.586)


   

HexCer 19:1;3O/17:0;(2OH)

HexCer 19:1;3O/17:0;(2OH)

C42H81NO10 (759.586)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (9Z,11E)-13-hydroperoxyoctadeca-9,11-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (9Z,11E)-13-hydroperoxyoctadeca-9,11-dienoate

C41H78NO9P (759.5414)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (5Z,8Z,14E)-11,12-dihydroxyicosa-5,8,14-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (5Z,8Z,14E)-11,12-dihydroxyicosa-5,8,14-trienoate

C41H78NO9P (759.5414)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-octacos-17-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-octacos-17-enoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] icosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] icosanoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] henicosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] henicosanoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] docosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] docosanoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetracosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetracosanoate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tricosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tricosanoate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C42H82NO8P (759.5778)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-henicosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-henicosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[10-(3-hexyloxiran-2-yl)decanoyloxy]propyl] (Z)-octadec-9-enoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[10-(3-hexyloxiran-2-yl)decanoyloxy]propyl] (Z)-octadec-9-enoate

C41H78NO9P (759.5414)


   

[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-icosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-icosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-nonadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] octadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] octadecanoate

C41H78NO9P (759.5414)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate

C41H78NO9P (759.5414)


   

[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (E)-10-hydroxyoctadec-12-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (E)-10-hydroxyoctadec-12-enoate

C41H78NO9P (759.5414)


   

[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] henicosanoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] icosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] icosanoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2S)-2-decanoyloxy-3-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

(5E,8E,11E,14E)-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

(5E,8E,11E,14E)-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

C45H77NO8 (759.5649)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-3-heptadecanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-heptadecanoyloxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-icos-11-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-icos-11-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[(E)-icos-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-icos-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] henicosanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] henicosanoate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2S)-3-icosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-icosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-3-nonadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-nonadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] henicosanoate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] icosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] icosanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] docosanoate

C42H82NO8P (759.5778)


   

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-hexadecanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-docos-13-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-tetracos-15-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-tetracos-15-enoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-2-nonadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-nonadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-decanoyloxy-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-icos-13-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-icos-13-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-icos-11-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-icos-11-enoate

C42H82NO8P (759.5778)


   

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexacos-5-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexacos-5-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] docosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] docosanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-docos-13-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-docos-13-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tricosanoate

C42H82NO8P (759.5778)


   

[(2R)-2-icosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-icosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C42H82NO8P (759.5778)


   

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tricosanoate

C42H82NO8P (759.5778)


   

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-heptadecanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-heptadecanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2S)-3-[(E)-icos-11-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-icos-11-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H82NO8P (759.5778)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-icos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-icos-13-enoate

C42H82NO8P (759.5778)


   

(5E,8E,11E,14E)-N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

(5E,8E,11E,14E)-N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,6-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

C45H77NO8 (759.5649)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] nonadecanoate

C42H82NO8P (759.5778)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

C42H82NO8P (759.5778)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[[(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytrideca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C44H76N2O6P+ (759.5441)


   

1-Oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

1-Oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


A phosphatidylcholine 34:1 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and palmitoyl respectively.

   

PC(20:0/14:1(9Z))

PC(20:0/14:1(9Z))

C42H82NO8P (759.5778)


   

1-(11Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

1-(11Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(9Z-tetradecenoyl)-2-eicosanoyl-glycero-3-phosphocholine

1-(9Z-tetradecenoyl)-2-eicosanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-tetradecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

1-tetradecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(11Z-eicosenoyl)-2-tetradecanoyl-glycero-3-phosphocholine

1-(11Z-eicosenoyl)-2-tetradecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-octadecanoyl-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

1-octadecanoyl-2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


A phosphatidylcholine 34:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (9Z)-hexadecenoyl respectively.

   

1-Palmitoleoyl-2-stearoyl-sn-glycero-3-phosphocholine

1-Palmitoleoyl-2-stearoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and stearoyl respectively.

   

1-palmitoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-palmitoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 11Z-octadecenoyl (cis-vaccenoyl) respectively.

   

PE-NMe(18:1(9Z)/18:0)

PE-NMe(18:1(9Z)/18:0)

C42H82NO8P (759.5778)


   

PE-NMe(18:0/18:1(9Z))

PE-NMe(18:0/18:1(9Z))

C42H82NO8P (759.5778)


   

PE-NMe(14:1(9Z)/22:0)

PE-NMe(14:1(9Z)/22:0)

C42H82NO8P (759.5778)


   

PE-NMe(16:1(9Z)/20:0)

PE-NMe(16:1(9Z)/20:0)

C42H82NO8P (759.5778)


   

PE-NMe(20:0/16:1(9Z))

PE-NMe(20:0/16:1(9Z))

C42H82NO8P (759.5778)


   

PE-NMe(22:0/14:1(9Z))

PE-NMe(22:0/14:1(9Z))

C42H82NO8P (759.5778)


   

PE-NMe(18:0/18:1(11Z))

PE-NMe(18:0/18:1(11Z))

C42H82NO8P (759.5778)


   

PE-NMe(16:0/20:1(11Z))

PE-NMe(16:0/20:1(11Z))

C42H82NO8P (759.5778)


   

PE-NMe(14:0/22:1(13Z))

PE-NMe(14:0/22:1(13Z))

C42H82NO8P (759.5778)


   

PE-NMe(18:1(11Z)/18:0)

PE-NMe(18:1(11Z)/18:0)

C42H82NO8P (759.5778)


   

PE-NMe(20:1(11Z)/16:0)

PE-NMe(20:1(11Z)/16:0)

C42H82NO8P (759.5778)


   

PE-NMe(22:1(13Z)/14:0)

PE-NMe(22:1(13Z)/14:0)

C42H82NO8P (759.5778)


   

PE-NMe2(15:0/20:1(11Z))

PE-NMe2(15:0/20:1(11Z))

C42H82NO8P (759.5778)


   

PE-NMe2(20:1(11Z)/15:0)

PE-NMe2(20:1(11Z)/15:0)

C42H82NO8P (759.5778)


   

Phophatidylethanolamine(15:0/22:1)

Phophatidylethanolamine(15:0/22:1)

C42H82NO8P (759.5778)


   

Phophatidylethanolamine(22:1/15:0)

Phophatidylethanolamine(22:1/15:0)

C42H82NO8P (759.5778)


   

1-octadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

1-octadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(9Z-pentadecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

1-(9Z-pentadecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-hexadecanoyl-2-(11E-octadecenoyl)-sn-glycero-3-phosphocholine

1-hexadecanoyl-2-(11E-octadecenoyl)-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-dodecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphocholine

1-dodecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-eicosanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

1-eicosanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(1Z-hexadecenyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphoserine

1-(1Z-hexadecenyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

1-(1Z-octadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

1-(1Z-eicosenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

1-(1Z-eicosenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C41H78NO9P (759.5414)


   

1-(9Z-pentadecenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

1-(9Z-pentadecenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-nonadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

1-nonadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(9Z-heptadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-heptadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(9Z-octadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-octadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-nonadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

1-nonadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-heneicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

1-heneicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-docosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

1-docosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-hexadecanoyl-2-(6E-octadecenoyl)-sn-glycero-3-phosphocholine

1-hexadecanoyl-2-(6E-octadecenoyl)-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-hexadecanoyl-2-(6Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-hexadecanoyl-2-(6Z-octadecenoyl)-sn-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-pentadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

1-pentadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-heptadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

1-heptadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(9Z-heptadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

1-(9Z-heptadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(9Z-nonadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

1-(9Z-nonadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-(9Z-hexadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-hexadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(9Z-nonadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-nonadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(11Z-docosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

1-(11Z-docosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C42H82NO8P (759.5778)


   

1-pentadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

1-pentadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-heptadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

1-heptadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(11Z-eicosenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

1-(11Z-eicosenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

1-(11Z-docosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

1-(11Z-docosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

C42H82NO8P (759.5778)


   

phosphatidylethanolamine (18:0/19:1)

phosphatidylethanolamine (18:0/19:1)

C42H82NO8P (759.5778)


A phosphatidylethanolamine 37:1 in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 19 carbons and 1 double bond.

   

phosphatidylcholine 34:1

phosphatidylcholine 34:1

C42H82NO8P (759.5778)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 1 double bond.

   

phosphatidylcholine (16:0/18:1)

phosphatidylcholine (16:0/18:1)

C42H82NO8P (759.5778)


A phosphatidylcholine 34:1 in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C18:1 respectively.

   

2,3-bis-O-(geranylgeranyl)-sn-glycero-3-phosphoethanolamine

2,3-bis-O-(geranylgeranyl)-sn-glycero-3-phosphoethanolamine

C45H78NO6P (759.5566)


A dialkylglycerophosphoethanolamine in which both alkyl groups are specified as geranylgeranyl.

   

PC(20:1(11Z)/14:0)

PC(20:1(11Z)/14:0)

C42H82NO8P (759.5778)


   

PC(14:1(9Z)/20:0)

PC(14:1(9Z)/20:0)

C42H82NO8P (759.5778)


   

2,3-bis-O-(geranylgeranyl)-sn-glycero-3-phosphoethanolamine zwitterion

2,3-bis-O-(geranylgeranyl)-sn-glycero-3-phosphoethanolamine zwitterion

C45H78NO6P (759.5566)


A zwitterion obtained by transfer of a proton from the phosphate to the amino group of a glycerophosphoethanolamine. Positions 1 and 2 of sn-glycero-3-phospho-ethanolamine are substituted by geranylgeranyl groups.

   

PC(14:0/20:1(11Z))

PC(14:0/20:1(11Z))

C42H82NO8P (759.5778)


   

PC(18:1(11Z)/16:0)

PC(18:1(11Z)/16:0)

C42H82NO8P (759.5778)


   

MePC(33:1)

MePC(15:0_18:1)

C42H82NO8P (759.5778)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(38:7)

Hex1Cer(t16:1_22:6)

C44H73NO9 (759.5285)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(35:1)

dMePE(17:0_18:1)

C42H82NO8P (759.5778)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(39:6)

Hex1Cer(d19:2_20:4)

C45H77NO8 (759.5649)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(16:0-18:1)

PC(16:0-18:1)

C42H82NO8P (759.5778)


PANOMIX internal lipid standards

   
   
   
   
   

PC O-16:0/18:2;O

PC O-16:0/18:2;O

C42H82NO8P (759.5778)


   

PC O-20:0/13:3;O2

PC O-20:0/13:3;O2

C41H78NO9P (759.5414)


   
   
   

PC P-16:0/18:1;O

PC P-16:0/18:1;O

C42H82NO8P (759.5778)


   
   
   
   
   
   
   
   

PC 14:1(9Z)/20:0

PC 14:1(9Z)/20:0

C42H82NO8P (759.5778)


   
   
   
   

PC 16:0/18:1(9Z)

PC 16:0/18:1(9Z)

C42H82NO8P (759.5778)


   
   

PC 16:1(7Z)/18:0

PC 16:1(7Z)/18:0

C42H82NO8P (759.5778)


   
   
   
   
   
   
   
   

PE O-16:0/20:3;O2

PE O-16:0/20:3;O2

C41H78NO9P (759.5414)


   
   

PE P-18:0/18:2;O2

PE P-18:0/18:2;O2

C41H78NO9P (759.5414)


   

PE P-18:1/18:1;O2

PE P-18:1/18:1;O2

C41H78NO9P (759.5414)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PS P-16:1/19:0 or PS O-16:2/19:0

PS P-16:1/19:0 or PS O-16:2/19:0

C41H78NO9P (759.5414)


   
   

PS P-18:0/17:1 or PS O-18:1/17:1

PS P-18:0/17:1 or PS O-18:1/17:1

C41H78NO9P (759.5414)


   
   

PS P-18:1/17:0 or PS O-18:2/17:0

PS P-18:1/17:0 or PS O-18:2/17:0

C41H78NO9P (759.5414)


   
   

PS P-20:0/15:1 or PS O-20:1/15:1

PS P-20:0/15:1 or PS O-20:1/15:1

C41H78NO9P (759.5414)


   
   

PS P-20:1/15:0 or PS O-20:2/15:0

PS P-20:1/15:0 or PS O-20:2/15:0

C41H78NO9P (759.5414)


   
   

PS P-22:1/13:0 or PS O-22:2/13:0

PS P-22:1/13:0 or PS O-22:2/13:0

C41H78NO9P (759.5414)


   
   

PS P-35:1 or PS O-35:2

PS P-35:1 or PS O-35:2

C41H78NO9P (759.5414)


   

GalCer 15:2;O2/24:4

GalCer 15:2;O2/24:4

C45H77NO8 (759.5649)


   

GalCer 17:0;O2/22:6

GalCer 17:0;O2/22:6

C45H77NO8 (759.5649)


   

GalCer 17:1;O2/22:5

GalCer 17:1;O2/22:5

C45H77NO8 (759.5649)


   

GalCer 17:2;O2/22:4

GalCer 17:2;O2/22:4

C45H77NO8 (759.5649)


   

GalCer 19:1;O2/20:5

GalCer 19:1;O2/20:5

C45H77NO8 (759.5649)


   

GalCer 19:2;O2/20:4

GalCer 19:2;O2/20:4

C45H77NO8 (759.5649)


   

GalCer 21:2;O2/18:4

GalCer 21:2;O2/18:4

C45H77NO8 (759.5649)


   

GalCer 39:6;O2

GalCer 39:6;O2

C45H77NO8 (759.5649)


   

GlcCer 15:2;O2/24:4

GlcCer 15:2;O2/24:4

C45H77NO8 (759.5649)


   

GlcCer 17:0;O2/22:6

GlcCer 17:0;O2/22:6

C45H77NO8 (759.5649)


   

GlcCer 17:1;O2/22:5

GlcCer 17:1;O2/22:5

C45H77NO8 (759.5649)


   

GlcCer 17:2;O2/22:4

GlcCer 17:2;O2/22:4

C45H77NO8 (759.5649)


   

GlcCer 19:1;O2/20:5

GlcCer 19:1;O2/20:5

C45H77NO8 (759.5649)


   

GlcCer 19:2;O2/20:4

GlcCer 19:2;O2/20:4

C45H77NO8 (759.5649)


   

GlcCer 21:2;O2/18:4

GlcCer 21:2;O2/18:4

C45H77NO8 (759.5649)


   

GlcCer 39:6;O2

GlcCer 39:6;O2

C45H77NO8 (759.5649)


   

HexCer 15:2;O2/24:4

HexCer 15:2;O2/24:4

C45H77NO8 (759.5649)


   

HexCer 17:0;O2/22:6

HexCer 17:0;O2/22:6

C45H77NO8 (759.5649)


   

HexCer 17:1;O2/22:5

HexCer 17:1;O2/22:5

C45H77NO8 (759.5649)


   

HexCer 17:2;O2/22:4

HexCer 17:2;O2/22:4

C45H77NO8 (759.5649)


   

HexCer 19:1;O2/20:5

HexCer 19:1;O2/20:5

C45H77NO8 (759.5649)


   

HexCer 19:2;O2/20:4

HexCer 19:2;O2/20:4

C45H77NO8 (759.5649)


   

HexCer 21:2;O2/18:4

HexCer 21:2;O2/18:4

C45H77NO8 (759.5649)


   

HexCer 39:6;O2

HexCer 39:6;O2

C45H77NO8 (759.5649)


   
   
   
   

(2-{[(2r)-3-(hexadecanoyloxy)-2-[(11z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2r)-3-(hexadecanoyloxy)-2-[(11z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)


   

(2-{[(2s)-3-(hexadecanoyloxy)-2-[(9z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2s)-3-(hexadecanoyloxy)-2-[(9z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5778)